nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—ABCB1—peripheral nervous system neoplasm	0.262	1	CbGaD
Ciprofloxacin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0768	0.148	CbGbCtD
Ciprofloxacin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.0598	0.115	CbGbCtD
Ciprofloxacin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0408	0.0785	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.039	0.075	CbGbCtD
Ciprofloxacin—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.039	0.075	CbGbCtD
Ciprofloxacin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0292	0.0562	CbGbCtD
Ciprofloxacin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0234	0.045	CbGbCtD
Ciprofloxacin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0205	0.0394	CbGbCtD
Ciprofloxacin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0205	0.0394	CbGbCtD
Ciprofloxacin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0187	0.036	CbGbCtD
Ciprofloxacin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0179	0.0344	CbGbCtD
Ciprofloxacin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0179	0.0344	CbGbCtD
Ciprofloxacin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0142	0.0273	CbGbCtD
Ciprofloxacin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0134	0.0258	CbGbCtD
Ciprofloxacin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0123	0.0237	CbGbCtD
Ciprofloxacin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0123	0.0236	CbGbCtD
Ciprofloxacin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0114	0.0219	CbGbCtD
Ciprofloxacin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00915	0.0176	CbGbCtD
Ciprofloxacin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00873	0.0168	CbGbCtD
Ciprofloxacin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00814	0.0157	CbGbCtD
Ciprofloxacin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.008	0.0154	CbGbCtD
Ciprofloxacin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00546	0.0105	CbGbCtD
Ciprofloxacin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00523	0.0101	CbGbCtD
Ciprofloxacin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00479	0.00923	CbGbCtD
Ciprofloxacin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00327	0.00629	CbGbCtD
Ciprofloxacin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00083	0.244	CbGdCrCtD
Ciprofloxacin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000493	0.145	CbGdCrCtD
Ciprofloxacin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000311	0.0913	CbGdCrCtD
Ciprofloxacin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000311	0.0913	CbGdCrCtD
Ciprofloxacin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000311	0.0913	CbGdCrCtD
Ciprofloxacin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000214	0.0628	CbGdCrCtD
Ciprofloxacin—Sparfloxacin—ABCB1—peripheral nervous system neoplasm	0.000175	0.587	CrCbGaD
Ciprofloxacin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.000162	0.0476	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.000162	0.0476	CbGdCrCtD
Ciprofloxacin—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000162	0.0476	CbGdCrCtD
Ciprofloxacin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.044	CbGdCrCtD
Ciprofloxacin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.044	CbGdCrCtD
Ciprofloxacin—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.044	CbGdCrCtD
Ciprofloxacin—Levofloxacin—ABCB1—peripheral nervous system neoplasm	0.000123	0.413	CrCbGaD
Ciprofloxacin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000192	CcSEcCtD
Ciprofloxacin—Renal failure—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000191	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	4.1e-05	0.000191	CcSEcCtD
Ciprofloxacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	4.1e-05	0.000191	CcSEcCtD
Ciprofloxacin—Fatigue—Etoposide—peripheral nervous system neoplasm	4.1e-05	0.000191	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.00019	CcSEcCtD
Ciprofloxacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.000189	CcSEcCtD
Ciprofloxacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.000189	CcSEcCtD
Ciprofloxacin—Pain—Etoposide—peripheral nervous system neoplasm	4.06e-05	0.000189	CcSEcCtD
Ciprofloxacin—Constipation—Etoposide—peripheral nervous system neoplasm	4.06e-05	0.000189	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	4.06e-05	0.000189	CcSEcCtD
Ciprofloxacin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000189	CcSEcCtD
Ciprofloxacin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000189	CcSEcCtD
Ciprofloxacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.03e-05	0.000187	CcSEcCtD
Ciprofloxacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.01e-05	0.000187	CcSEcCtD
Ciprofloxacin—Sweating—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000186	CcSEcCtD
Ciprofloxacin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000186	CcSEcCtD
Ciprofloxacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000185	CcSEcCtD
Ciprofloxacin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000184	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000184	CcSEcCtD
Ciprofloxacin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000183	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	3.92e-05	0.000182	CcSEcCtD
Ciprofloxacin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000182	CcSEcCtD
Ciprofloxacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	3.9e-05	0.000181	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000181	CcSEcCtD
Ciprofloxacin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000181	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	3.89e-05	0.000181	CcSEcCtD
Ciprofloxacin—Dizziness—Vincristine—peripheral nervous system neoplasm	3.88e-05	0.00018	CcSEcCtD
Ciprofloxacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	3.87e-05	0.00018	CcSEcCtD
Ciprofloxacin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.00018	CcSEcCtD
Ciprofloxacin—Infestation—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.00018	CcSEcCtD
Ciprofloxacin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.00018	CcSEcCtD
Ciprofloxacin—Rash—Alitretinoin—peripheral nervous system neoplasm	3.84e-05	0.000179	CcSEcCtD
Ciprofloxacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	3.84e-05	0.000178	CcSEcCtD
Ciprofloxacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000178	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	3.82e-05	0.000178	CcSEcCtD
Ciprofloxacin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000178	CcSEcCtD
Ciprofloxacin—Headache—Alitretinoin—peripheral nervous system neoplasm	3.81e-05	0.000177	CcSEcCtD
Ciprofloxacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000177	CcSEcCtD
Ciprofloxacin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000176	CcSEcCtD
Ciprofloxacin—Urticaria—Etoposide—peripheral nervous system neoplasm	3.78e-05	0.000176	CcSEcCtD
Ciprofloxacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000175	CcSEcCtD
Ciprofloxacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000175	CcSEcCtD
Ciprofloxacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000175	CcSEcCtD
Ciprofloxacin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000175	CcSEcCtD
Ciprofloxacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	3.76e-05	0.000175	CcSEcCtD
Ciprofloxacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	3.76e-05	0.000175	CcSEcCtD
Ciprofloxacin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000175	CcSEcCtD
Ciprofloxacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000174	CcSEcCtD
Ciprofloxacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000174	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000174	CcSEcCtD
Ciprofloxacin—Vomiting—Vincristine—peripheral nervous system neoplasm	3.73e-05	0.000174	CcSEcCtD
Ciprofloxacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	3.72e-05	0.000173	CcSEcCtD
Ciprofloxacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000173	CcSEcCtD
Ciprofloxacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000172	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000172	CcSEcCtD
Ciprofloxacin—Rash—Vincristine—peripheral nervous system neoplasm	3.7e-05	0.000172	CcSEcCtD
Ciprofloxacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	3.7e-05	0.000172	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000172	CcSEcCtD
Ciprofloxacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000171	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000171	CcSEcCtD
Ciprofloxacin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	3.68e-05	0.000171	CcSEcCtD
Ciprofloxacin—Headache—Vincristine—peripheral nervous system neoplasm	3.68e-05	0.000171	CcSEcCtD
Ciprofloxacin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.00017	CcSEcCtD
Ciprofloxacin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	3.65e-05	0.00017	CcSEcCtD
Ciprofloxacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	3.62e-05	0.000168	CcSEcCtD
Ciprofloxacin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000168	CcSEcCtD
Ciprofloxacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000168	CcSEcCtD
Ciprofloxacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	3.55e-05	0.000165	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000165	CcSEcCtD
Ciprofloxacin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000164	CcSEcCtD
Ciprofloxacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000163	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	3.5e-05	0.000163	CcSEcCtD
Ciprofloxacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000163	CcSEcCtD
Ciprofloxacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000162	CcSEcCtD
Ciprofloxacin—Nausea—Vincristine—peripheral nervous system neoplasm	3.49e-05	0.000162	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000162	CcSEcCtD
Ciprofloxacin—Flushing—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000162	CcSEcCtD
Ciprofloxacin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000162	CcSEcCtD
Ciprofloxacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000161	CcSEcCtD
Ciprofloxacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000161	CcSEcCtD
Ciprofloxacin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000161	CcSEcCtD
Ciprofloxacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	3.44e-05	0.00016	CcSEcCtD
Ciprofloxacin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000159	CcSEcCtD
Ciprofloxacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000159	CcSEcCtD
Ciprofloxacin—Asthenia—Etoposide—peripheral nervous system neoplasm	3.41e-05	0.000159	CcSEcCtD
Ciprofloxacin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000159	CcSEcCtD
Ciprofloxacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	3.4e-05	0.000158	CcSEcCtD
Ciprofloxacin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	3.4e-05	0.000158	CcSEcCtD
Ciprofloxacin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000158	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000157	CcSEcCtD
Ciprofloxacin—Chills—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000157	CcSEcCtD
Ciprofloxacin—Pruritus—Etoposide—peripheral nervous system neoplasm	3.36e-05	0.000156	CcSEcCtD
Ciprofloxacin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	3.35e-05	0.000156	CcSEcCtD
Ciprofloxacin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000156	CcSEcCtD
Ciprofloxacin—Alopecia—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000154	CcSEcCtD
Ciprofloxacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	3.3e-05	0.000153	CcSEcCtD
Ciprofloxacin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000153	CcSEcCtD
Ciprofloxacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000153	CcSEcCtD
Ciprofloxacin—Rash—Cisplatin—peripheral nervous system neoplasm	3.27e-05	0.000152	CcSEcCtD
Ciprofloxacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	3.27e-05	0.000152	CcSEcCtD
Ciprofloxacin—Erythema—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000152	CcSEcCtD
Ciprofloxacin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000152	CcSEcCtD
Ciprofloxacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	3.25e-05	0.000151	CcSEcCtD
Ciprofloxacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000151	CcSEcCtD
Ciprofloxacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000151	CcSEcCtD
Ciprofloxacin—Flushing—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.00015	CcSEcCtD
Ciprofloxacin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.00015	CcSEcCtD
Ciprofloxacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.22e-05	0.00015	CcSEcCtD
Ciprofloxacin—Tension—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000149	CcSEcCtD
Ciprofloxacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000149	CcSEcCtD
Ciprofloxacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000147	CcSEcCtD
Ciprofloxacin—Back pain—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000147	CcSEcCtD
Ciprofloxacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	3.15e-05	0.000146	CcSEcCtD
Ciprofloxacin—Dizziness—Etoposide—peripheral nervous system neoplasm	3.14e-05	0.000146	CcSEcCtD
Ciprofloxacin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000146	CcSEcCtD
Ciprofloxacin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000146	CcSEcCtD
Ciprofloxacin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000145	CcSEcCtD
Ciprofloxacin—Chills—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000145	CcSEcCtD
Ciprofloxacin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000144	CcSEcCtD
Ciprofloxacin—Nausea—Cisplatin—peripheral nervous system neoplasm	3.08e-05	0.000143	CcSEcCtD
Ciprofloxacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000143	CcSEcCtD
Ciprofloxacin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000143	CcSEcCtD
Ciprofloxacin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	3.04e-05	0.000141	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.000141	CcSEcCtD
Ciprofloxacin—Vomiting—Etoposide—peripheral nervous system neoplasm	3.02e-05	0.000141	CcSEcCtD
Ciprofloxacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000141	CcSEcCtD
Ciprofloxacin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000141	CcSEcCtD
Ciprofloxacin—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.00014	CcSEcCtD
Ciprofloxacin—Agitation—Epirubicin—peripheral nervous system neoplasm	3e-05	0.00014	CcSEcCtD
Ciprofloxacin—Rash—Etoposide—peripheral nervous system neoplasm	3e-05	0.000139	CcSEcCtD
Ciprofloxacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	2.99e-05	0.000139	CcSEcCtD
Ciprofloxacin—Headache—Etoposide—peripheral nervous system neoplasm	2.98e-05	0.000139	CcSEcCtD
Ciprofloxacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	2.98e-05	0.000138	CcSEcCtD
Ciprofloxacin—Tension—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000138	CcSEcCtD
Ciprofloxacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000138	CcSEcCtD
Ciprofloxacin—Malaise—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000137	CcSEcCtD
Ciprofloxacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000136	CcSEcCtD
Ciprofloxacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000136	CcSEcCtD
Ciprofloxacin—Syncope—Epirubicin—peripheral nervous system neoplasm	2.93e-05	0.000136	CcSEcCtD
Ciprofloxacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000136	CcSEcCtD
Ciprofloxacin—Back pain—Doxorubicin—peripheral nervous system neoplasm	2.92e-05	0.000136	CcSEcCtD
Ciprofloxacin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000135	CcSEcCtD
Ciprofloxacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	2.88e-05	0.000134	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000133	CcSEcCtD
Ciprofloxacin—Cough—Epirubicin—peripheral nervous system neoplasm	2.85e-05	0.000133	CcSEcCtD
Ciprofloxacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000132	CcSEcCtD
Ciprofloxacin—Convulsion—Epirubicin—peripheral nervous system neoplasm	2.83e-05	0.000132	CcSEcCtD
Ciprofloxacin—Nausea—Etoposide—peripheral nervous system neoplasm	2.82e-05	0.000131	CcSEcCtD
Ciprofloxacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000131	CcSEcCtD
Ciprofloxacin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.00013	CcSEcCtD
Ciprofloxacin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	2.79e-05	0.00013	CcSEcCtD
Ciprofloxacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000129	CcSEcCtD
Ciprofloxacin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000129	CcSEcCtD
Ciprofloxacin—Myalgia—Epirubicin—peripheral nervous system neoplasm	2.78e-05	0.000129	CcSEcCtD
Ciprofloxacin—Agitation—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000129	CcSEcCtD
Ciprofloxacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	2.77e-05	0.000129	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	2.76e-05	0.000128	CcSEcCtD
Ciprofloxacin—Discomfort—Epirubicin—peripheral nervous system neoplasm	2.75e-05	0.000128	CcSEcCtD
Ciprofloxacin—Malaise—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000127	CcSEcCtD
Ciprofloxacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	2.72e-05	0.000126	CcSEcCtD
Ciprofloxacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000126	CcSEcCtD
Ciprofloxacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	2.71e-05	0.000126	CcSEcCtD
Ciprofloxacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000126	CcSEcCtD
Ciprofloxacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	2.69e-05	0.000125	CcSEcCtD
Ciprofloxacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	2.67e-05	0.000124	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000124	CcSEcCtD
Ciprofloxacin—Oedema—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000124	CcSEcCtD
Ciprofloxacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000124	CcSEcCtD
Ciprofloxacin—Cough—Doxorubicin—peripheral nervous system neoplasm	2.64e-05	0.000123	CcSEcCtD
Ciprofloxacin—Shock—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000122	CcSEcCtD
Ciprofloxacin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	2.62e-05	0.000122	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	2.61e-05	0.000122	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	2.61e-05	0.000121	CcSEcCtD
Ciprofloxacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000121	CcSEcCtD
Ciprofloxacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000121	CcSEcCtD
Ciprofloxacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.00012	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.00012	CcSEcCtD
Ciprofloxacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.00012	CcSEcCtD
Ciprofloxacin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.00012	CcSEcCtD
Ciprofloxacin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	2.57e-05	0.00012	CcSEcCtD
Ciprofloxacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	2.56e-05	0.000119	CcSEcCtD
Ciprofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	2.55e-05	0.000119	CcSEcCtD
Ciprofloxacin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000118	CcSEcCtD
Ciprofloxacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000118	CcSEcCtD
Ciprofloxacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000117	CcSEcCtD
Ciprofloxacin—Hypotension—Epirubicin—peripheral nervous system neoplasm	2.49e-05	0.000116	CcSEcCtD
Ciprofloxacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	2.49e-05	0.000116	CcSEcCtD
Ciprofloxacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000115	CcSEcCtD
Ciprofloxacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000115	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000113	CcSEcCtD
Ciprofloxacin—Shock—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000113	CcSEcCtD
Ciprofloxacin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	2.42e-05	0.000112	CcSEcCtD
Ciprofloxacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000112	CcSEcCtD
Ciprofloxacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.41e-05	0.000112	CcSEcCtD
Ciprofloxacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	2.41e-05	0.000112	CcSEcCtD
Ciprofloxacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000111	CcSEcCtD
Ciprofloxacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000111	CcSEcCtD
Ciprofloxacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	2.38e-05	0.000111	CcSEcCtD
Ciprofloxacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.00011	CcSEcCtD
Ciprofloxacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.00011	CcSEcCtD
Ciprofloxacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000109	CcSEcCtD
Ciprofloxacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.35e-05	0.000109	CcSEcCtD
Ciprofloxacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.32e-05	0.000108	CcSEcCtD
Ciprofloxacin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000107	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.3e-05	0.000107	CcSEcCtD
Ciprofloxacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.3e-05	0.000107	CcSEcCtD
Ciprofloxacin—Pain—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.000106	CcSEcCtD
Ciprofloxacin—Constipation—Epirubicin—peripheral nervous system neoplasm	2.28e-05	0.000106	CcSEcCtD
Ciprofloxacin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	0.000104	CcSEcCtD
Ciprofloxacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	0.000104	CcSEcCtD
Ciprofloxacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000103	CcSEcCtD
Ciprofloxacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000102	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.000102	CcSEcCtD
Ciprofloxacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.19e-05	0.000102	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.18e-05	0.000101	CcSEcCtD
Ciprofloxacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	0.000101	CcSEcCtD
Ciprofloxacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	9.97e-05	CcSEcCtD
Ciprofloxacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.13e-05	9.9e-05	CcSEcCtD
Ciprofloxacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.13e-05	9.89e-05	CcSEcCtD
Ciprofloxacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.12e-05	9.85e-05	CcSEcCtD
Ciprofloxacin—Pain—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	9.81e-05	CcSEcCtD
Ciprofloxacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.11e-05	9.81e-05	CcSEcCtD
Ciprofloxacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.11e-05	9.8e-05	CcSEcCtD
Ciprofloxacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.11e-05	9.8e-05	CcSEcCtD
Ciprofloxacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.03e-05	9.45e-05	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	9.38e-05	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.96e-05	9.13e-05	CcSEcCtD
Ciprofloxacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	1.96e-05	9.11e-05	CcSEcCtD
Ciprofloxacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	9.07e-05	CcSEcCtD
Ciprofloxacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	9.07e-05	CcSEcCtD
Ciprofloxacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.91e-05	8.89e-05	CcSEcCtD
Ciprofloxacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	1.88e-05	8.77e-05	CcSEcCtD
Ciprofloxacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.82e-05	8.48e-05	CcSEcCtD
Ciprofloxacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.82e-05	8.45e-05	CcSEcCtD
Ciprofloxacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.77e-05	8.23e-05	CcSEcCtD
Ciprofloxacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.76e-05	8.2e-05	CcSEcCtD
Ciprofloxacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	8.11e-05	CcSEcCtD
Ciprofloxacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.69e-05	7.88e-05	CcSEcCtD
Ciprofloxacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.69e-05	7.85e-05	CcSEcCtD
Ciprofloxacin—Rash—Epirubicin—peripheral nervous system neoplasm	1.68e-05	7.81e-05	CcSEcCtD
Ciprofloxacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.68e-05	7.81e-05	CcSEcCtD
Ciprofloxacin—Headache—Epirubicin—peripheral nervous system neoplasm	1.67e-05	7.76e-05	CcSEcCtD
Ciprofloxacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.63e-05	7.58e-05	CcSEcCtD
Ciprofloxacin—Nausea—Epirubicin—peripheral nervous system neoplasm	1.58e-05	7.36e-05	CcSEcCtD
Ciprofloxacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	1.57e-05	7.29e-05	CcSEcCtD
Ciprofloxacin—Rash—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	7.23e-05	CcSEcCtD
Ciprofloxacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	7.22e-05	CcSEcCtD
Ciprofloxacin—Headache—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	7.18e-05	CcSEcCtD
Ciprofloxacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	6.81e-05	CcSEcCtD
